Turnstone Biologics Corp TSBX IPO will take place July, 21 on the NASDAQ exchange under the ticker TSBX.
The company is offering shares at an expected price between $12.00 and $14.00 per share with an insider lock-up period of 180 days ending on January 17, 2024.
See also: Benzinga IPO Calendar
About Turnstone Biologics Corp
Turnstone Biologics Corp are strongly positioned to be a leader in leveraging viral immunotherapy to further potentiate the clinical benefit of TILs. Viruses are naturally adept at reprogramming the TME, and we believe that our proprietary viral immunotherapies can be tailored to drive the best combination approach for TILs
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
